Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion [Phase 2]
Phase 2 study evaluating the efficacy and safety of HSK31858 tablets in patients with airway mucus hypersecretion; the trial is currently en…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: High Intensity Interval Training and Inspiratory Muscle Training [NA]
The clinical trial evaluating high-intensity interval training and inspiratory muscle training in patients with Chronic Obstructive Pulmonar…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Once Daily Long-Acting Muscarinic Antagonists Administered in the Evening for Prevention of Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization or Death from Any Cause [Phase 4]
A Phase 4 clinical trial evaluating once-daily long-acting muscarinic antagonists for preventing COPD exacerbations requiring hospitalizatio…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Tezepelumab COPD Exacerbation Study [Phase 2]
Phase 2 trial of tezepelumab for COPD exacerbations has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Metformin to Reduce Airway Glucose in COPD Patients [Phase 2]
Phase 2 trial evaluating metformin to reduce airway glucose in COPD patients has completed; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2025-02-18EMA Authorised: GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.) (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
The European Medicines Agency authorised GoResp Digihaler, a budesonide/formoterol inhalation therapy by Teva Pharma B.V. (previously Budeso…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: RELVAR Effects on Parasternal Muscle Activity, Diaphragm, and Ventilation in Severe COPD [Phase 4]
Phase 4 trial evaluating RELVAR's effects on parasternal muscle activity, diaphragm function, and ventilation in adults with severe chronic …
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: Effect of Powerbreath Versus Transcutaneous Electrical Diaphragmatic Stimulation on The Severity of Copd [NA]
A completed clinical trial compares Powerbreath to transcutaneous electrical diaphragmatic stimulation to assess effects on the severity of …
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Communication During Hospitalization About Resuscitation Trial [Phase 2, Phase 3]
An ongoing Phase 2/Phase 3 trial assesses communication about resuscitation preferences during hospitalization for patients with severe life…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Chronic Airway Disease and Multimorbidity Cohort
A prospective cohort clinical trial on chronic airway disease and multimorbidity is currently recruiting, involving COPD, asthma, and bronch…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Lung Health of Early COPD: A Multi-center Cohort Study
This clinical trial is a multi-center cohort study evaluating lung health in individuals with early chronic obstructive pulmonary disease an…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment [Phase 3]
Phase 3 multicenter randomized non-inferiority trial evaluating an investigational asthma/COPD treatment from Eurofarma has completed.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) [Phase 3]
Phase 3 clinical trial evaluating a triple inhaled therapy consisting of Fluticasone, Formoterol, and Glycopyrronium for chronic obstructive…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Evaluation of 3D Magnetic Resonance Spirometry: Comparison with Spirometry in Healthy Subjects and Patients with Respiratory Pathologies (asthma, COPD, Bilateral Lung Transplant) [NA]
A clinical trial evaluating 3D magnetic resonance spirometry and its comparison with conventional spirometry in healthy subjects and patient…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Evaluation of Immunological, Microbiological and Metabolomic Profiles in COPD
A completed clinical trial from Medical University of Warsaw studied immunological, microbiological, and metabolomic profiles in chronic obs…
-
FDA approval · 2025-02-13FDA Approved: PREDNISOLONE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental Abbreviated New Drug Application for a generic prednisolone product from PAI Holdings/PAI Pharma, signaling regu…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects [Phase 1]
Phase 1 trial assessing the safety, tolerability, and pharmacokinetics of CHF6523 in healthy individuals and patients with chronic obstructi…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Bronchodilators and Lung Mechanics During Exercise in COPD [Phase 4]
Phase 4 clinical trial evaluating the effects of bronchodilators on lung mechanics during exercise in chronic obstructive pulmonary disease.…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Metoprolol in Patients With HFrEF and COPD [Phase 4]
A Phase 4 trial of metoprolol in patients with heart failure with reduced ejection fraction and COPD is planned, with status not yet recruit…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Prevalence of Sarcopenic Obesity in COPD
This clinical trial update reports on the prevalence of sarcopenic obesity in people with chronic obstructive pulmonary disease (COPD) and n…
-
FDA approval · 2025-02-12FDA Approved: ACETYLCYSTEINE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for acetylcysteine from Somerset Therapeutics, LLC, granting approval for a generic acetylcysteine pro…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Effect of an Individual Counseling Session on Physical Activity Level of Individuals With COPD [NA]
This clinical trial update notes the completion of a study assessing whether an individual counseling session affects physical activity leve…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease [NA]
A clinical trial update notes a study on myofascial release in COPD patients; the trial is not yet recruiting.
-
FDA approval · 2025-02-11FDA Approved: FORMOTEROL FUMARATE — Original Application (Devatis, Inc.)
FDA approved the original application (ANDA) for Formoterol Fumarate Dihydrate, the generic form of Formoterol Fumarate, manufactured by Dev…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: Comparison Between Levofloxacin and Prulifloxacin, in Internal Medicine Patients With Acute Exacerbation of COPD [Phase 4]
A Phase 4 study comparing levofloxacin and prulifloxacin in patients with acute exacerbation of COPD; the trial has completed and results ha…